We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

20 hedge funds and large institutions have $4.32M invested in Armata Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

0.14% more ownership

Funds ownership: 4.64% → 4.78% (+0.14%)

5% less funds holding

Funds holding: 21 → 20 (-1)

6% less capital invested

Capital invested by funds: $4.59M → $4.32M (-$277K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
8
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SF
Synovus Financial
Georgia
+$95.2K
2
BlackRock
BlackRock
New York
+$70.7K
3
BCM
Bridgeway Capital Management
Texas
+$34.3K
4
UBS Group
UBS Group
Switzerland
+$5.47K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.87K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$40.4K
2
Millennium Management
Millennium Management
New York
-$40K
3
Morgan Stanley
Morgan Stanley
New York
-$3.23K
4
Bank of America
Bank of America
North Carolina
-$583
5
Osaic Holdings
Osaic Holdings
Arizona
-$133
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
1
Bank of America
North Carolina
$2.29M -$583 -153 -0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$610K +$4.87K +1,280 +0.8%
BCM
3
Bridgeway Capital Management
Texas
$443K +$34.3K +9,000 +8%
Renaissance Technologies
4
Renaissance Technologies
New York
$384K -$40.4K -10,604 -9%
Edgewood Management
5
Edgewood Management
Connecticut
$181K – – –
SF
6
Synovus Financial
Georgia
$174K +$95.2K +25,000 +108%
BlackRock
7
BlackRock
New York
$74K +$70.7K +18,570 +928%
SWM
8
SeaCrest Wealth Management
New York
$49K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$43K +$3.46K +910 +8%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$36K – – –
UBS Group
11
UBS Group
Switzerland
$11K +$5.47K +1,436 +98%
Morgan Stanley
12
Morgan Stanley
New York
$4K -$3.23K -849 -43%
SSB
13
Sandy Spring Bank
Maryland
$4K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$3K +$3.08K +808 +1,393%
Osaic Holdings
15
Osaic Holdings
Arizona
$2K -$133 -35 -7%
Northwestern Mutual Wealth Management
16
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
Millennium Management
17
Millennium Management
New York
– -$40K -10,055 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– -$8 -2 -4%
Wells Fargo
19
Wells Fargo
California
– +$46 +12 +24%

ARMP Hedge Fund Activity: Q3 2021 in Review

20 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q3 2021, worth a combined $4.32M — down 6% from $4.59M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ARMP and 0 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 8 added.

The largest buyer was Synovus Financial, adding an estimated $95.2K. The largest seller was Renaissance Technologies, cutting an estimated $40.4K.

  • 20 institutional investors held Armata Pharmaceuticals (ARMP) as of Q3 2021, down from 21 in Q2 2021.
  • Funds reported $4.32M of Armata Pharmaceuticals stock for Q3 2021, down 6% quarter-over-quarter.
  • 0 funds opened new Armata Pharmaceuticals positions in Q3 2021 and 1 closed out, a net change of -1 holder.
  • The largest Armata Pharmaceuticals buyer in Q3 2021 was Synovus Financial, an estimated $95.2K added.
  • The largest Armata Pharmaceuticals seller in Q3 2021 was Renaissance Technologies, an estimated $40.4K sold.

Based on aggregated 13F filings for Q3 2021.